Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Jensen Insider Profile
4 Followers
Peter Jensen, Director at Allergy Therapeutics, holds 2.10M shares in Allergy Therapeutics (Ticker: GB:AGY). Most recently, Peter Jensen Bought 1,800,000p shares of Allergy Therapeutics on Oct 13, 2023 for an estimated value of 18.00K.
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+63.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Peter Jensen holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 13, 2023 - Oct 13, 2024
Return:+214.80%
The most profitable trade made by Peter Jensen
Peter Jensen's Trading History
List of latest transactions for each holding click on a transaction to see Peter Jensen's performance on stock
You May Also Like
Peter Jensen insider profile FAQ
What is the percentage of profitable transactions made by Peter Jensen?
The percentage of profitable transactions made by Peter Jensen is 60%.
What is the average return per transaction made by Peter Jensen?
The average return per transaction made by Peter Jensen is 63.50%.
What stocks does Peter Jensen hold?
Peter Jensen holds: GB:AGY stocks.
What was Peter Jensen’s latest transaction?
Peter Jensen latest transaction was an Informative Buy of 18.00K.
What was Peter Jensen's most profitable transaction?
Peter Jensen’s most profitable transaction was an Informative Buy of GB:AGY stock on October 13, 2023. The return on the trade was 214.80%.
What is Peter Jensen's role in Allergy Therapeutics?
Peter Jensen's role in Allergy Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.